tiprankstipranks
Keros Therapeutics (KROS)
NASDAQ:KROS
US Market
Holding KROS?
Track your performance easily

Keros Therapeutics (KROS) Technical Analysis

304 Followers

Technical Sentiment

Overall Consensus
Strong Sell
5Bullish
0Neutral
17Bearish
Technical Analysis Consensus
Neutral
5Bullish
0Neutral
5Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Keros Therapeutics’s (KROS) Moving Averages Convergence Divergence (MACD) indicator is -7.79, suggesting Keros Therapeutics is a Sell.
Keros Therapeutics’s (KROS) 20-Day exponential moving average is 18.43, while Keros Therapeutics’s (KROS) share price is $10.86, making it a Sell.
Keros Therapeutics’s (KROS) 50-Day exponential moving average is 32.27, while Keros Therapeutics’s (KROS) share price is $10.86, making it a Sell.

Keros Therapeutics (KROS) Pivot Points

Jan 21, 2025, 09:54 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.57
9.83
10.18
10.44
10.79
11.05
11.40
Fibonacci
9.83
10.07
10.21
10.44
10.68
10.82
11.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Keros Therapeutics (KROS) Moving Averages

Jan 21, 2025, 09:54 AM
Period
Simple
Exponential
MA5
11.42Sell
11.59Sell
MA10
13.41Sell
13.24Sell
MA20
14.98Sell
18.43Sell
MA50
39.54Sell
32.27Sell
MA100
48.03Sell
41.63Sell
MA200
49.45Sell
47.80Sell
Keros Therapeutics’s (KROS) 10-Day exponential moving average is 13.24, while Keros Therapeutics’s (KROS) share price is $10.86, making it a Sell.
Keros Therapeutics’s (KROS) 100-Day exponential moving average is 41.63, while Keros Therapeutics’s (KROS) share price is $10.86, making it a Sell.
Keros Therapeutics’s (KROS) stock price is $10.86 and Keros Therapeutics’s (KROS) 50-day simple moving average is 39.54, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $10.86 and Keros Therapeutics’s (KROS) 100-day simple moving average is 48.03, creating a Sell signal.
Keros Therapeutics’s (KROS) stock price is $10.86 and Keros Therapeutics’s (KROS) 200-day simple moving average is 49.45, creating a Sell signal.

Keros Therapeutics (KROS) Technical Indicators

Jan 21, 2025, 09:54 AM
Name
Value
Implied Action
RSI (14)
20.25
Buy
STOCH (9,6)
12.17
Buy
STOCHRSI (14)
11.04
Buy
MACD (12,26)
-7.79
Sell
ADX (14)
50.11
Sell
Williams %R
-85.48
Buy
CCI (14)
-144.22
Buy
ATR (14)
2.23
-
Ultimate Oscillator
28.21
Sell
ROC
-35.40
Sell
Keros Therapeutics’s (KROS) Relative Strength Index (RSI) is 20.25, creating a Buy signal.
Keros Therapeutics’s (KROS) Trend Strength Indicator (ADX) is 50.11, creating a Sell signal.
Keros Therapeutics’s (KROS) Commodity Channel Index (CCI) is -144.22, creating a Buy signal.
Keros Therapeutics’s (KROS) Price Rate of Change (ROC) is -35.40, creating a Sell signal.

FAQ

Is KROS a Buy, Hold, or Sell?
Based on KROS’s technical indicators, KROS is a Strong Sell.
    What is KROS’s RSI (14)?
    KROS’s RSI (14) is 20.25, which suggests KROS is a Buy.
      What is KROS’s MACD?
      KROS’s MACD is -7.79, which suggests KROS is a Sell.
        What is KROS’s 5-day moving average?
        KROS’s 5-day moving average is 11.42, which suggests KROS is a Sell.
          What is KROS’s 20-day moving average?
          KROS 20-day moving average is 14.98, which suggests KROS is a Sell.
            What is KROS’s 50-day moving average?
            KROS’s 50-day moving average is 39.54, which suggests KROS is a Sell.
              What is KROS’s 200-day moving average?
              KROS’s 200-day moving average is 49.45, which suggests KROS is a Sell.
                What is KROS’s Williams % R (14)?
                KROS’s Williams % R (14) is -85.48, which suggests KROS is a Buy.
                  What is KROS’s CCI (14)?
                  KROS’s CCI (14) is -144.22, which suggests KROS is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis